Literature DB >> 8896941

Responsive polymeric drug delivery systems. Meeting the patient's needs.

A D'Emanuele1.   

Abstract

Current approaches to the development of drug delivery systems are based typically on the premise that the relationship between the plasma concentration and therapeutic effect of a drug is invariant with time. Release kinetics from these systems are, therefore, usually engineered to be either zero-order or a simple function of time. It has been recognised for some time, however, that this approach may not be appropriate for certain drugs and it has been suggested that therapeutic efficacy may be improved by the utilisation of triggered, pulsed and programmed delivery systems. This article considers an approach to the development of responsive drug delivery system based on the utilisation of functional polymers, which aim to improve therapeutic efficacy by varying drug release in accordance with a patients's varying requirements.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896941     DOI: 10.2165/00003088-199631040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  10 in total

Review 1.  New methods of drug delivery.

Authors:  R Langer
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

2.  Ultrasound-enhanced polymer degradation and release of incorporated substances.

Authors:  J Kost; K Leong; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Collapse of gels in an electric field.

Authors:  T Tanaka; I Nishio; S T Sun; S Ueno-Nishio
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

4.  4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991.

Authors:  Allan S Hoffman
Journal:  J Control Release       Date:  2014-09-28       Impact factor: 9.776

5.  Concanavalin A microspheres for a self-regulating insulin delivery system.

Authors:  C M Pai; Y H Bae; E J Mack; D E Wilson; S W Kim
Journal:  J Pharm Sci       Date:  1992-06       Impact factor: 3.534

6.  Electrically erodible polymer gel for controlled release of drugs.

Authors:  I C Kwon; Y H Bae; S W Kim
Journal:  Nature       Date:  1991-11-28       Impact factor: 49.962

7.  Magnetic modulation of release of macromolecules from polymers.

Authors:  D S Hsieh; R Langer; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  A glucose-controlled insulin-delivery system: semisynthetic insulin bound to lectin.

Authors:  M Brownlee; A Cerami
Journal:  Science       Date:  1979-12-07       Impact factor: 47.728

9.  Glucose-sensitive membranes containing glucose oxidase: activity, swelling, and permeability studies.

Authors:  J Kost; T A Horbett; B D Ratner; M Singh
Journal:  J Biomed Mater Res       Date:  1985 Nov-Dec

Review 10.  Circadian rhythms and cancer chemotherapy.

Authors:  C Focan
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

  10 in total
  3 in total

Review 1.  Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.

Authors:  G K Gourlay
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

2.  Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma.

Authors:  J Qureshi; Mohd Amir; Alka Ahuja; Sanjula Baboota; J Ali
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

3.  Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release.

Authors:  Mayur Desai; Rishad R Jivani; Laxman D Patel; Noordin P Jivani; Bhavin Sonagara
Journal:  Int J Pharm Investig       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.